Home / Resource Library / Ibrutinib plus R-CHOP followed by maintenance in untreated ABC-DLBCL patients with IPI >2: A first analysis of phase II Study FIL_RI-CHOP
Ibrutinib plus R-CHOP followed by maintenance in untreated ABC-DLBCL patients with IPI >2: A first analysis of phase II Study FIL_RI-CHOP